| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 136, 5034-5041, Copyright © 1995 by Endocrine Society
ARTICLES |
PB Brake and CR Jefcoate
Center for Environmental Toxicology, University of Wisconsin, Madison 53706, USA.
Cytochrome P4501B1 (CYP1B1), which is responsible for metabolism of 7,12-dimethylbenz[a]anthracene in the rat adrenal gland, is partially dependent on ACTH in vivo. The regulation of CYP1B1 and possible involvement in steroidogenesis have been characterized in cultured rat adrenocortical cells. Relatively high basal expression of CYP1B1 is maintained in vitro and is, therefore, independent of ACTH. CYP1B1 expression is elevated 4-fold in primary cultures of fasciculata cells after 24 h of ACTH treatment, as measured by selective 7,12- dimethylbenz[a]anthracene metabolism, immunoblot analysis, and parallel changes in the 5.2-kilobase CYP1B1 messenger RNA (mRNA). Corticosterone synthesis was stimulated about 40-fold in these cells after this ACTH treatment. Maximal stimulation of CYP1B1 protein and mRNA by ACTH has been duplicated in fasciculata cells by 8-bromo-cAMP and the adenylyl cyclase agonist, forskolin, indicating that cAMP mediates this induction. CYP1B1 is similarly stimulated by ACTH in rat adrenal glomerulosa cells, although constitutive expression of CYP1B1 is about 4-fold lower. Angiotensin II treatment of glomerulosa cells, which stimulated aldosterone synthesis 3-fold, had no effect on CYP1B1 activity or expression. Treatment of fasciculata and glomerulosa cells with 2,3,7,8-tetrachlorodibenzo-p-dioxin resulted in small increases in CYP1B1 activity (1.8- and 2.5-fold, respectively), but much larger increases (5- and 6-fold, respectively) in CYP1B1 at the mRNA level 2,3,7,8-Tetrachlorodibenzo-p-dioxin had no effect in the presence of ACTH stimulation. CYP1B1 is not coordinately expressed with steroidogenic enzymes. CYP11A1 and CYP21 mRNAs are far more responsive to ACTH, in part because of lower basal expression. CYP1B1 exhibited a transient response to ACTH that peaked (9-fold) at 6 h before declining to about 4-fold at 36 h, the time when CYP21 mRNA was maximally stimulated. The complete inactivation of CYP1B1 activity in fasciculata cells by a mechanism-based inhibitor, 1-ethynylpyrene, did not affect corticosterone production, indicating that this protein does not have a direct physiological role in the steroidogenic response.
This article has been cited by other articles:
![]() |
J. T. Chang, H. Chang, P.-H. Chen, S.-L. Lin, and P. Lin Requirement of Aryl Hydrocarbon Receptor Overexpression for CYP1B1 Up-Regulation and Cell Growth in Human Lung Adenocarcinomas Clin. Cancer Res., January 1, 2007; 13(1): 38 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tsuchiya, M. Nakajima, S. Takagi, M. Katoh, W. Zheng, C. R Jefcoate, and T. Yokoi Binding of Steroidogenic Factor-1 to the Regulatory Region Might Not Be Critical for Transcriptional Regulation of the Human CYP1B1 Gene. J. Biochem., March 1, 2006; 139(3): 527 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zheng and C. R. Jefcoate Steroidogenic Factor-1 Interacts with cAMP Response Element-Binding Protein to Mediate cAMP Stimulation of CYP1B1 via a Far Upstream Enhancer Mol. Pharmacol., February 1, 2005; 67(2): 499 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Port, K. Yamaguchi, B. Du, M. De Lorenzo, M. Chang, P. M. Heerdt, L. Kopelovich, C. B. Marcus, N. K. Altorki, K. Subbaramaiah, et al. Tobacco smoke induces CYP1B1 in the aerodigestive tract Carcinogenesis, November 1, 2004; 25(11): 2275 - 2281. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. P. Artemenko, D. Zhao, D. B. Hales, K. H. Hales, and C. R. Jefcoate Mitochondrial Processing of Newly Synthesized Steroidogenic Acute Regulatory Protein (StAR), but Not Total StAR, Mediates Cholesterol Transfer to Cytochrome P450 Side Chain Cleavage Enzyme in Adrenal Cells J. Biol. Chem., November 30, 2001; 276(49): 46583 - 46596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Sanderson, L. Slobbe, G. W. A. Lansbergen, S. Safe, and M. van den Berg 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Diindolylmethanes Differentially Induce Cytochrome P450 1A1, 1B1, and 19 in H295R Human Adrenocortical Carcinoma Cells Toxicol. Sci., May 1, 2001; 61(1): 40 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Ghanayem, Hongbing Wang, and S. Sumner Using Cytochrome P-450 Gene Knock-Out Mice to Study Chemical Metabolism, Toxicity, and Carcinogenicity Toxicol Pathol, November 1, 2000; 28(6): 839 - 850. [Abstract] [PDF] |
||||
![]() |
P. B. Brake, M. Arai, S. As-Sanie, C. R. Jefcoate, and E. P. Widmaier Developmental Expression and Regulation of Adrenocortical Cytochrome P4501B1 in the Rat Endocrinology, April 1, 1999; 140(4): 1672 - 1680. [Abstract] [Full Text] |
||||
![]() |
J. T. M. Buters, S. Sakai, T. Richter, T. Pineau, D. L. Alexander, U. Savas, J. Doehmer, J. M. Ward, C. R. Jefcoate, and F. J. Gonzalez Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas PNAS, March 2, 1999; 96(5): 1977 - 1982. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Tang, G.-F. Chen, P. A. Thompson, D.-X. Lin, N. P. Lang, and F. F. Kadlubar Development of an AntiPeptide Antibody That Binds to the C-Terminal Region of Human CYP1B1 Drug Metab. Dispos., February 1, 1999; 27(2): 274 - 280. [Abstract] [Full Text] |
||||
![]() |
L. Zhang, U. Savas, D. L. Alexander, and C. R. Jefcoate Characterization of the Mouse Cyp1B1 Gene. IDENTIFICATION OF AN ENHANCER REGION THAT DIRECTS ARYL HYDROCARBON RECEPTOR-MEDIATED CONSTITUTIVE AND INDUCED EXPRESSION J. Biol. Chem., February 27, 1998; 273(9): 5174 - 5183. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Alexander, L. Ganem, P Fernandez-Salguero, F Gonzalez, and C. Jefcoate Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis J. Cell Sci., January 11, 1998; 111(22): 3311 - 3322. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |